Are you a professional? Activate your profile

Are you already registered? Access Forgot your password?

Financial advisors
Calculation tools
- Calculates the risk and return of a securities portfolio
- Calculate your supplementary pension
Funds / ETFs / Stock Ranking
Learn about finance
- Financial glossary
- Learning to invest
  The most important concepts of finance
Study Office
- Asset allocation
- Finance app ranking
About us

Enveric Biosciences Inc. - news published 259 - readings 4.347

BACK

Enveric Biosciences Inc.

Initial Statement of Beneficial Ownership (Form 3)

The text version of this document is not available. You can access the original document here . Attachments Original document Permalink Disclaimer Enveric Biosciences Inc. published this content on 15 October 2021 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 15 October 2021 23:15:10 UTC .

15.10.2021

Enveric Biosciences Inc.

Statement of Changes in Beneficial Ownership (Form 4)

15.10.2021

Enveric Biosciences Inc.

Amendment to Statement of Changes in Beneficial Ownership (Form 4/A)

The text version of this document is not available. You can access the original document here . Attachments Original document Permalink Disclaimer Enveric Biosciences Inc. published this content on 12 October 2021 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 12 October 2021 22:19:07 UTC .

12.10.2021

Enveric Biosciences Inc.

Enveric Biosciences Announces Artificial Intelligence Platform, PsyAITM, Has Identified Viable Drug Candidates from its ‘Psybrary’ of Psychedelic Molecular Compounds (Form 8-K)

Enveric Biosciences Announces Artificial Intelligence Platform, PsyAI TM , Has Identified Viable Drug Candidates from its 'Psybrary' of Psychedelic Molecular Compounds -Paving the way to select lead drug candidates for preclinical studies to support clinical evaluation in cancer-related distress - NAPLES, Fla., October 5, 2021 - Enveric Biosciences (NASDAQ: ENVB) ("Enveri ...

05.10.2021

Enveric Biosciences Inc.

Initial Insider Trading Report (SEC Filing - 3)

The text version of this document is not available. You can access the original document here . Attachments Original document Permalink Disclaimer Enveric Biosciences Inc. published this content on 27 September 2021 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 27 September 2021 20:40:16 UTC .

27.09.2021

Enveric Biosciences Inc.

Insider Trading Report (SEC Filing - 4)

The text version of this document is not available. You can access the original document here . Attachments Original document Permalink Disclaimer Enveric Biosciences Inc. published this content on 27 September 2021 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 27 September 2021 20:40:15 UTC .

27.09.2021

Enveric Biosciences Inc.

Insider Trading Report (SEC Filing - 4)

The text version of this document is not available. You can access the original document here . Attachments Original document Permalink Disclaimer Enveric Biosciences Inc. published this content on 27 September 2021 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 27 September 2021 20:40:12 UTC .

27.09.2021

Enveric Biosciences Inc.

Initial Insider Trading Report (SEC Filing - 3)

The text version of this document is not available. You can access the original document here . Attachments Original document Permalink Disclaimer Enveric Biosciences Inc. published this content on 27 September 2021 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 27 September 2021 20:30:01 UTC .

27.09.2021

Enveric Biosciences Inc.

Submission of Matters to a Vote of Security Holders (Form 8-K)

Submission of Matters to a Vote of Security Holders. On September 14, 2021, Enveric Biosciences, Inc. (the 'Company') held its 2021 annual meeting of stockholders (the 'Annual Meeting'). Five proposals were included in the notice of Annual Meeting for consideration at the Annual Meeting. At the Annual Meeting, stockholders of the Company voted on the following four proposals, ...

14.09.2021

Enveric Biosciences Inc.

Material Event (Form 8-K)

Other Events. On September 2, 2021, Vince Mojta ('Plaintiff'), through his attorney, filed a complaint ( Mojta v. Enveric Biosciences, Inc., et al., Case No. 1:21-cv-07385 (S.D.N.Y.)) in the United States District Court for the Southern District of New York, against Enveric Biosciences, Inc. (the 'Company') and the members of its board of directors (the 'Directors'). The compl ...

03.09.2021

Enveric Biosciences Inc.

Notice of Effectiveness (SEC Filing - EFFECT)

The text version of this document is not available. You can access the original document here . Attachments Original document Permalink Disclaimer Enveric Biosciences Inc. published this content on 06 August 2021 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 09 August 2021 11:22:49 UTC .

09.08.2021

Enveric Biosciences Inc.

Supplemental Prospectus (SEC Filing - 424B3)

Filed Pursuant to Rule 424(b)(3) Registration No. 333-257272 Proxy Statement/ProSpectus AN AMALGAMATION IS PROPOSED - YOUR VOTE IS VERY IMPORTANT To the Stockholders of Enveric Biosciences, Inc.: On May 24, 2021, Enveric Biosciences, Inc., a Delaware corporation ('ENVB'), entered into an Amalgamation Agreement (the 'Amalgamation Agreement') with 1306432 B.C. Ltd., a corporatio ...

06.08.2021

Enveric Biosciences Inc.

Amendment to Registration of Securities issued in Business Combination Transaction (SEC Filing - S-4/A)

Exhibit 99.1 Consent of Gemini Valuation Services, LLC Gemini Valuation Services, LLC ('Gemini') hereby consents to (i) the inclusion of our opinion letter dated May 21, 2021 (the 'Opinion') to the Board of Directors of Enveric Biosciences, Inc. as Annex D to the proxy statement/prospectus that is being filed on or promptly after the date hereof with the Securities and Exchang ...

04.08.2021

Enveric Biosciences Inc.

Shareholder Director Nominations (Form 8-K)

Shareholder Director Nominations. As previously reported on a Current Report on Form 8-K filed by Enveric Biosciences, Inc. (the ' Company ') with the Securities and Exchange Commission (' SEC ') on May 24, 2021, the Company entered into that certain amalgamation agreement with MagicMed Industries Inc. (' MagicMed '), pursuant to which, among other things, the amalgamated corp ...

06.07.2021

Enveric Biosciences Inc.

Registration Statement - Specified Transactions (SEC Filing - S-3)

As filed with the U.S. Securities and Exchange Commission on July 2, 2021 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ENVERIC BIOSCIENCES, INC. (Exact name of registrant as specified in its charter) Delaware 95-4484725 (State or other jurisdiction of incorporation ...

02.07.2021

Enveric Biosciences Inc. - news published 259 - readings 4.347

Enveric Biosciences Inc.

Initial Statement of Beneficial Ownership (Form 3)

Enveric Biosciences Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Enveric Biosciences Inc.

Amendment to Statement of Changes in Beneficial Ownership (Form 4/A)

Enveric Biosciences Inc.

Enveric Biosciences Announces Artificial Intelligence Platform, PsyAITM, Has Identified Viable Drug Candidates from its ‘Psybrary’ of Psychedelic Molecular Compounds (Form 8-K)

Enveric Biosciences Inc.

Initial Insider Trading Report (SEC Filing - 3)

Enveric Biosciences Inc.

Insider Trading Report (SEC Filing - 4)

Enveric Biosciences Inc.

Insider Trading Report (SEC Filing - 4)

Enveric Biosciences Inc.

Initial Insider Trading Report (SEC Filing - 3)

Enveric Biosciences Inc.

Submission of Matters to a Vote of Security Holders (Form 8-K)

Enveric Biosciences Inc.

Material Event (Form 8-K)

Enveric Biosciences Inc.

Notice of Effectiveness (SEC Filing - EFFECT)

Enveric Biosciences Inc.

Supplemental Prospectus (SEC Filing - 424B3)

Enveric Biosciences Inc.

Amendment to Registration of Securities issued in Business Combination Transaction (SEC Filing - S-4/A)

Enveric Biosciences Inc.

Shareholder Director Nominations (Form 8-K)

Enveric Biosciences Inc.

Registration Statement - Specified Transactions (SEC Filing - S-3)

You have reached the maximum number of requests. You can no longer send.

Become Member

€2,99per month

Become Member

€2,99per month

You have reached the maximum
number of requests.
You can no longer send.

Become
Member

Become
Member